Related Experiment Video
Updated: Jul 21, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement
Tanush Gupta1, Joshua Zimmer1, Rony N Lahoud1
1Division of Cardiology, University of Vermont Medical Center, Burlington, Vermont, USA.
Insights
Transcatheter aortic valve replacement (TAVR) patients experiencing acute myocardial infarction (AMI) had similar revascularization rates but higher in-hospital mortality for ST-elevation MI (STEMI) compared to non-TAVR patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Health Services Research
Background:
- Prior studies suggest reduced invasive management for acute myocardial infarction (AMI) in patients who have undergone transcatheter aortic valve replacement (TAVR).
- Understanding the impact of prior TAVR on subsequent AMI care and outcomes is crucial for contemporary patient management.
Purpose of the Study:
- To investigate if a history of TAVR influences the utilization of coronary revascularization and the in-hospital outcomes of patients experiencing AMI.
- To analyze these effects within a large, contemporary national dataset.
Main Methods:
- A retrospective analysis of consecutive TAVR patients from 2016-2022 using the U.S. Vizient Clinical Data Base.
- Comparison of patients with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) with or without prior TAVR.
- Propensity score matching was employed to control for baseline patient characteristic differences.
Main Results:
- Among 206,229 TAVR patients, STEMI occurred at 25/100,000 person-years and NSTEMI at 229/100,000 person-years.
- Post-matching, coronary revascularization rates for STEMI (65.3% vs 63.9%) and NSTEMI (41.4% vs 41.7%) were similar between prior TAVR and no prior TAVR groups.
- In-hospital mortality was higher for STEMI in the prior TAVR group (27.1% vs 16.7%) but lower for NSTEMI (5.8% vs 8.2%) compared to the no prior TAVR group.
Conclusions:
- Acute myocardial infarction events following TAVR are infrequent.
- Coronary revascularization rates for STEMI and NSTEMI do not differ between TAVR patients and the general population.
- In-hospital mortality following STEMI is elevated in patients with a history of TAVR.
Background:
Prior studies have reported decreased use of an invasive approach for acute myocardial infarction (AMI) in patients undergoing transcatheter aortic valve replacement (TAVR).
Objectives:
The aim of this study was to determine whether prior TAVR affects the use of subsequent coronary revascularization and outcomes of AMI in a contemporary national data set.
Methods:
Consecutive TAVR patients from 2016 to 2022 were identified from the U.S. Vizient Clinical Data Base who were hospitalized after the index TAVR hospitalization with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI). Patients with STEMI or NSTEMI with or without prior TAVR from the same time period were compared for the use of coronary angiography, revascularization, and in-hospital outcomes. Propensity score matching was used to account for imbalances in patient characteristics.
Results:
Among 206,229 patients who underwent TAVR, the incidence of STEMI was 25 events per 100,000 person-years of follow-up, and that of NSTEMI was 229 events per 100,000 person-years. After propensity matching, the use of coronary revascularization was similar in the prior TAVR and no TAVR cohorts in both the STEMI (65.3% vs 63.9%; P = 0.81) and NSTEMI (41.4% vs 41.7%; P = 0.88) subgroups. Compared with patients without prior TAVR, in-hospital mortality was higher in the prior TAVR cohort in patients with STEMI (27.1% vs 16.7%; P = 0.03) and lower in those with NSTEMI (5.8% vs 8.2%; P = 0.02).
Conclusions:
In this large, national retrospective study, AMI events after TAVR were infrequent. There were no differences in the use of coronary revascularization for STEMI or NSTEMI in TAVR patients compared with the non-TAVR population. In-hospital mortality for STEMI is higher in TAVR patients compared with those without prior TAVR.
More Related Videos
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

